Skip to main content

Lakefront Biotherapeutics NV 6-K, filed Nov 12, 2026

Lakefront Biotherapeutics NV (LKFT)

6-K 2026-11-12 For: 2026-11-11
View Original
Added on November 12, 2026

About this 6-K

Lakefront Biotherapeutics NV filed this 6-K on November 12, 2026.

Lakefront reported €13.9 million net profit for the first nine months of 2026 and expects year-end 2026 cash and financial investments of €2.0 to €2.05 billion, including a second €50 million share repurchase program. AI summary